SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-010025
Filing Date
2019-05-15
Accepted
2019-05-15 14:47:57
Documents
3
Period of Report
2019-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inbp20190515_8k.htm 8-K 38239
2 EXHIBIT 99.1 PRESS RELEASE DATED MAY 15 2019 EARNINGS RELEASE AND REFINANCING ex_145031.htm EX-99.1 89180
3 ibp_logo.jpg GRAPHIC 12671
  Complete submission text file 0001437749-19-010025.txt   145866
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 19827263
SIC: 2834 Pharmaceutical Preparations